Guidance for the treatment and prevention of obstetric-associated venous thromboembolism
Shannon M. BatesDepartment of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute (TaARI), 1280 Main Street West, HSC 3W11, Hamilton, ON, L8S 4K1, Canada. [email protected]Saskia MiddeldorpDepartment of Vascular Medicine, University of Amsterdam, Amsterdam, The NetherlandsMarc RodgerDepartments of Medicine, Epidemiology and Community Medicine, and Obstetrics and Gynecology, University of Ottawa, Ottawa, ON, CanadaAllison JamesDepartment of Obstetrics and Gynecology, Duke University, Durham, NC, USAIan GreerFaculty of Medical and Human Sciences, The University of Manchester, Manchester, UK
2016en
ABI
Аннотация
Venous thromboembolism (VTE), which may manifest as pulmonary embolism (PE) or deep vein thrombosis (DVT), is a serious and potentially fatal condition. Treatment and prevention of obstetric-related VTE is complicated by the need to consider fetal, as well as maternal, wellbeing when making management decisions. Although absolute VTE rates in this population are low, obstetric-associated VTE is an important cause of maternal morbidity and mortality. This manuscript, initiated by the Anticoagulation Forum, provides practical clinical guidance on the prevention and treatment of obstetric-associated VTE based on existing guidelines and consensus expert opinion based on available literature where guidelines are lacking.
Перевод пока недоступен
Идентификаторы
Цитирования и источники
Цитирований: 3Использованных источников: 0